Healthcare IT News March 10, 2025
Bill Siwicki

If the DEA’s role is not properly limited, there could be an overreach where the agency influences or even dictates how healthcare practitioners make decisions, which could impact patient care, says Dan Cohen, president of RTM company Adhere+.

The U.S. Drug Enforcement Administration has proposed draft guidance to establish a framework for prescribing controlled substances via telemedicine.

The proposal introduces three types of special registrations. Telemedicine prescribing registration allows qualified practitioners to prescribe Schedule III-V controlled substances via telemedicine. Advanced telemedicine prescribing registration permits specialized practitioners, such as psychiatrists and hospice care physicians, to prescribe Schedule II-V controlled substances via telemedicine. And telemedicine platform registration enables online telemedicine platforms to dispense Schedule II-V controlled substances through registered practitioners.

The guidance...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Digital Health, Govt Agencies, Provider, Technology, Telehealth
Related Articles:
Another Reprieve? Proposed Budget Bill Includes Telehealth, HaH Extensions
A Mis-Trust Hangover for Health Care 5 Years After COVID Began – an Edelman Trust Barometer Update
House expected to consider CR to fund government through Sept. 30, extend key health care provisions
ACIP’s Upcoming Meningococcal Recommendations: Added Complexity, Reduced Choice
Federal research cuts could worsen infectious disease toll worldwide, expert warns

Share This Article